Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.50 |
| ▸ | MEN1 | O00255 | 4/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | HPGD | P15428 | 3/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.50 |
| ▸ | IMPDH2 | P12268 | 1/20 | 0.50 |
| ▸ | NTRK1 | P04629 | 2/20 | 0.47 |
| ▸ | DAPK3 | O43293 | 1/20 | 0.47 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.47 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.47 |
| ▸ | ABL1 | P00519 | 1/20 | 0.47 |
| ▸ | LCK | P06239 | 1/20 | 0.47 |
| ▸ | FYN | P06241 | 1/20 | 0.47 |
| ▸ | CSF1R | P07333 | 1/20 | 0.47 |
| ▸ | RET | P07949 | 1/20 | 0.47 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL128472 | 1.00 | MAPT (0.50) | MAPTMEN1KMT2AKDM4EALDH1A1 | |
| SCHEMBL5003596 | 1.00 | MAPT (0.50) | MAPTMEN1KMT2AKDM4EALDH1A1 | |
| SCHEMBL3467529 | 0.73 | NTRK1 (0.56) | MAPTMEN1KMT2AKDM4EALDH1A1 | |
| SCHEMBL3467350 | 0.73 | NTRK1 (0.56) | MAPTMEN1KMT2AKDM4EALDH1A1 | |
| SCHEMBL3467353 | 0.73 | NTRK1 (0.56) | MAPTMEN1KMT2AKDM4EALDH1A1 | |
| SCHEMBL5145062 | 0.72 | NAT1 (0.43) | MEN1KMT2AALDH1A1SMN1; SMN2NFKB1 | |
| SCHEMBL16111817 | 0.72 | NAT1 (0.43) | MEN1KMT2AALDH1A1SMN1; SMN2NFKB1 | |
| SCHEMBL3781740 | 0.71 | LMNA (0.46) | MAPTMEN1KMT2AKDM4EALDH1A1 | |
| SCHEMBL26425931 | 0.71 | MEN1 (0.61) | MAPTMEN1KMT2AKDM4EALDH1A1 | |
| SCHEMBL860566 | 0.70 | KDM4E (0.49) | MAPTMEN1KMT2AKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10877035-B2 | Advanced drug development and manufacturing | ICAGEN, LLC (US) | 2020-12-29 | — | — | US | disclosed |
| US-20150309021-A1 | Advanced Drug Development and Manufacturing | LOS ALAMOS NATIONAL SECURITY, LLC | 2015-10-29 | — | — | US | disclosed |
| EP-2511844-B1 | X-ray microscope | XRPRO SCIENCES INC (US) | 2015-08-12 | — | — | EP | disclosed |
| EP-2511844-A2 | Advanced drug development and manufacturing | Los Alamos National Security, LLC (US) | 2012-10-17 | — | — | EP | disclosed |
| US-8278120-B2 | Method of changing fluorescence wavelength of fluorescent protein | NEC SOFT, LTD. (JP) | 2012-10-02 | — | — | US | disclosed |
| EP-2084519-B1 | X-RAY FLUORESCENCE ANALYSIS METHOD | LOS ALAMOS NAT SECURITY LLC (US) | 2012-08-01 | — | — | EP | disclosed |
| EP-1988161-B1 | METHOD OF CHANGING FLUORESCENCE WAVELENGTH OF FLUOROPROTEIN | NEC SOFTWARE LTD (JP) | 2012-03-07 | — | — | EP | disclosed |
| US-20090318673-A1 | METHOD OF CHANGING FLUORESCENCE WAVELENGTH OF FLUORESCENT PROTEIN | NEC SOFT, LTD. (JP) | 2009-12-24 | — | — | US | disclosed |
| EP-2084519-A2 | ADVANCED DRUG DEVELOPMENT AND MANUFACTURING | Los Alamos National Security, LLC (US) | 2009-08-05 | — | — | EP | disclosed |
| EP-1988161-A1 | METHOD OF CHANGING FLUORESCENCE WAVELENGTH OF FLUOROPROTEIN | Nec Soft, LTD. (JP) | 2008-11-05 | — | — | EP | disclosed |
| WO-2008127291-A2 | ADVANCED DRUG DEVELOPMENT AND MANUFACTURING | LOS ALAMOS NATIONAL SECURITY, LLC (US) | 2008-10-23 | — | — | WO | disclosed |
| US-20080220441-A1 | Advanced drug development and manufacturing | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2008-09-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090318673-A1 | METHOD OF CHANGING FLUORESCENCE WAVELENGTH OF FLUORESCENT PROTEIN | GPKOW, GLMN, FIBP | MAPT 1814/4885MEN1 4142/4885KMT2A 3804/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.